Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Klear Optix was a medical device company specializing in the development of hybrid contact lenses for the treatment of keratoconus and other corneal irregularities. The company's primary innovation was the KlearKone lens, which combined a rigid gas permeable center with a soft outer skirt to provide the visual clarity of a hard lens with the comfort of a soft lens. This technology was specifically engineered to vault over the irregular cone-shaped cornea of keratoconus patients, offering a significant improvement over traditional lens designs. In January 2012, Klear Optix was acquired by SynergEyes, a leading manufacturer of hybrid contact lenses, which integrated the KlearKone technology into its specialized product line. The acquisition enabled the broader commercialization of this technology to eye care professionals and patients worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Klear Optix.